The Arabinose (Ara) Genetic Marker

Background

The Escherichia coli B strain REL606 has a mutation in the araA gene that renders it unable to utilize the sugar L-arabinose. Strain REL607 is a spontaneous revertant of REL606 containing a single point mutation that restores the ability to metabolize L-arabinose. This marker is selectively neutral in a variety of conditions and can be used to determine the relative frequencies of Ara⁻ (REL606-derived) and Ara⁺ (REL607-derived) cells in a mixture for competition assays or marker divergence experiments. Ara⁻ and Ara⁺ cells form red and white colonies, respectively, on tetrazolium arabinose (TA) plates, because utilization of the sugar rather than only the tryptone and yeast extract components of this medium causes the excretion of acetic acid which acidifies the area surrounding the colony, changing the tetrazolium indicator color from red to white.

Selection for arabinose utilization from REL606 is known to also produce, more rarely, Ara⁺ revertants that have an araA 92A (GCC) sequence.

Selection of Ara⁺ Revertants from Ara⁻ Strains Derived from REL606

General Procedure

For a non-mutator strain. Grow several 10 ml cultures in DM1000 media (LB is also fine in most situations). Spin down to concentrate cells and plate them all on separate minimal arabinose (MA) plates. Grow for 48 hours, pick one colony from each plate (it has to be an Ara⁺ revertant to grow). Streak each candidate colony on a new MA plate and grow overnight to verify that it is Ara⁺ and a clone. Then, grow an overnight culture in LB or DM1000 and store frozen. For a mutator strain, you can plate 1/10 to 1/100th as many cells and expect to get the same number of Ara+ revertants.

Detailed Procedure

Supplies

Day 1: Revive

1. Revive strains to be tested from the freezer in DM1000 in 5 ml cultures in test tubes or 10 ml cultures in 50 ml Erlenmeyer flasks.
2. Incubate shaking at 120 RPM at 37°C overnight.

Day 2: Grow replicates

Day 3: Plate on Selective Media

1. Pour each DM1000 culture into a 15 ml Falcon tube.
2. Pellet cells by spinning for 15 minutes at 4,000 rpm in the Eppendorf 5810R with the swinging bucket rotor.
3. Carefully pour the supernatant out of each tube, leaving a few hundred µl of liquid at the bottom.
4. Using a 1 ml pipetor, pipet up and down to re-suspend the cells in the remaining liquid into a dense milkshake.
5. Plate this entire volume on 1 Minimal Arabinose (MA) plate.
6. Incubate MA plates at 37°C for 36–48 hours.

Variant: This procedure is for a strain with a normal wild-type mutation rate. For a mutator strain it is generally sufficient to plate 100–200 µl of a dense overnight culture directly on the MA plates.

Day 5:

1. At this point, you should have several colonies on most plates. Sometimes a plate will have zero cells. Sometimes it might have hundreds or thousands (a jackpot). For more about this distribution, read about fluctuation tests.
2. Pick ONE colony from each plate and streak it out on a new MA plate. This extra step ensures that you have isolated your new strain from the hazy background of Ara– cells and that it is not a mixture of two Ara+ revertants.
3. Incubate MA plates at 37°C for 36–48 hours.

Day 6:

1. Pick a single colony from each plate into a test tube filled with 5 ml of DM1000.
2. Incubate cultures shaking at 120 RPM at 37°C overnight.

Day 7:

1. Freeze down each strain. Label these cryovials with a temporary designation. Only once a clone passes the PCR-RFLP test to be sure it has the appropriate mutation and a co-culture competition test for fitness neutrality should the strain be given a permanent designation and entered in the strain database.

PCR-RFLP Assay for Verifying the REL607 Mutation

To verify that you have the precise reversion present in REL607 in your new Ara⁺ revertant candidate, you can use PCR followed by digestion with a restriction enzyme that cuts only when the REL607 allele is present.

Perform a standard PCR reaction from whole cells with these two primers.

Cut with HaeII and run on a 3% agarose gel. Ara⁺ with the REL607 reversion mutation will show a shift of the 226 bp band down into the composite ~200 bp band because this mutation creates an additional copy of the restriction site.

The expected result is that a majority (>50%) of selected Ara⁺ revertants have this exact mutation.